Oruka Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-18.5M | $-16.4M | $-11.4M | $-9.7M | $-6.9M | $-4.3M | $-5.4M | $-8.4M |
| Depreciation & Amortization | $27.0K | $24.0K | $19.0K | $12.0K | $26.0K | $43.0K | $602.0K | $338.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $458.0K | $576.0K | $599.0K | $647.0K | $283.0K | $306.0K | $308.0K | $458.0K |
| Net Cash from Operating Activities | $-17.5M | $-15.0M | $-10.5M | $-9.4M | $-5.3M | $-4.1M | $-7.0M | $-8.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.0K | $12.0K | $11.0K | $19.0K | $32.0K | — | $19.0K | $4.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $12.9M | — | — | — | $-32.0K | — | $2.0M | $265.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.8M | — | — | — | $19.2M | $1.1M | $3.9M | $7.3M |
| Net Change in Cash | $1.3M | — | — | $-1.4M | $13.8M | $-3.0M | $-1.1M | $-738.0K |
| Free Cash Flow | $-17.5M | $-15.0M | $-10.5M | $-9.4M | $-5.3M | — | $-7.0M | $-8.3M |